OTHER FINANCIAL INFORMATION - Schedule of Prepaid Expense and Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Clinical drug substance and product manufacturing	$ 2,480	$ 1,998
Clinical trials	1,682	3,544
Software licenses	1,219	816
Outside research and development services	766	642
Other	283	382
Prepaid expense and other current assets	$ 6,430	$ 7,382

Clinical Drug Substance and Product Manufacturing, Prepaid Expense Current

No definition available.

Name:	inhibrx_ClinicalDrugSubstanceAndProductManufacturingPrepaidExpenseCurrent
Namespace Prefix:	inhibrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Clinical Trails, Prepaid Expense Current

+ References

No definition available.

+ Details

Name:	inhibrx_ClinicalTrailsPrepaidExpenseCurrent
Namespace Prefix:	inhibrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Outside Research And Development Services, Prepaid Expense Current

+ References

No definition available.

+ Details

Name:	inhibrx_OutsideResearchAndDevelopmentServicesPrepaidExpenseCurrent
Namespace Prefix:	inhibrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Software License, Prepaid Current

+ References

No definition available.

+ Details

Name:	inhibrx_SoftwareLicensePrepaidCurrent
Namespace Prefix:	inhibrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of current assets classified as other.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_OtherAssetsCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant